VitalDose® EVA: Therapeutic Solutions And Form Factors

VitalDose® EVA is a versatile drug delivery platform designed for the development of long-acting controlled release therapeutics. The biocompatible copolymer allows formulators to create implants loaded with various therapeutic agents, including biologics, peptides, small molecules, and RNA.

VitalDose EVA offers significant design flexibility, enabling precise control over drug release profiles ranging from months to years. This tunability caters to diverse therapeutic needs. The platform boasts a well-established regulatory history with approvals in numerous pharmaceutical and medical device applications. Existing dose forms demonstrate successful implementation in subcutaneous implants, surgical implants, intravaginal rings, and intravitreal implants.

For researchers seeking customized formulations, Celanese provides development services through its dedicated laboratory, ensuring technical feasibility. Additionally, comprehensive regulatory support is available, including Drug Master Files and technical guidance, streamlining customer approval processes. Furthermore, VitalDose EVA excipients are manufactured under stringent quality control practices adhering to Good Manufacturing Practices (GMP) requirements. Learn how this innovative drug delivery platform can improve your controlled release therapeutic program.